Synthesis and Biological Evaluation of Imidazolium Conjugated with Dimethylcardamonin (DMC) As a Novel Potential Agent Against MDA-MB-231 Triple-Negative Breast Cancer Cells
Biomedicine & Pharmacotherapy(2024)
Key words
Triple-negative breast cancer,MDA-MB-231,Syzygium nervosum,2',4'-Dihydroxy-6'-methoxy-3',5'-dimethylchalcone,Dimethylcardamonin,Imidazolium ionic liquids
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined